FIELD: chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely a cyclic amine derivative or a pharmacologically acceptable salt thereof of general formula (I), wherein the carbon atom marked with * is an asymmetric carbon atom and A is a group represented by the general formula (IIa), (IIb) or (IIc), where R1 is a methyl group or an ethyl group optionally substituted by a halogen atom, R2 represents a hydrogen atom or an alkylcarbonyl group having from 2 to 5 carbon atoms, each R3 independently represents a methyl group or an ethyl group, and n is 1 or 2. Invention also relates to a medicament, an analgesic and a therapeutic agent based on a compound of formula (I). 
, 
.
EFFECT: cyclic amine derivative having an analgesic effect is obtained, in particular with respect to neuropathic pain and/or fibromyalgia syndrome.
10 cl, 18 dwg, 8 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVE CYCLIC AMINE AND ITS PHARMACEUTICAL APPLICATION | 2014 |
|
RU2638549C2 |
| CYCLICAMINE DERIVATIVE AS A MEANS OF STIMULATION OF THE ACTION OF ADVILLIN AND A NEW CYCLICAMINE DERIVATIVE AND ITS APPLICATION IN PHARMACEUTICALS | 2019 |
|
RU2792056C2 |
| CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 2017 |
|
RU2719384C1 |
| AGENT FOR INHIBITION OF INCREASE IN INTRA-NEURAL CALCIUM CONCENTRATION | 2019 |
|
RU2783208C2 |
| THERAPEUTIC REMEDY OR PREVENTIVE REMEDY AGAINST ALOPECIA AREATA | 2018 |
|
RU2772507C2 |
| CYCLIC AMINE DERIVATIVE AND ITS MEDICAL APPLICATION | 2017 |
|
RU2696862C1 |
| DIHYDROINDOLONE DERIVATIVES | 2009 |
|
RU2468022C2 |
| TRISUBSTITUTED IMIDAZOLES SHOWING THERAPEUTIC PROPERTIES, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1994 |
|
RU2140918C1 |
| C-FMC KINASE INHIBITORS | 2007 |
|
RU2475483C2 |
| PHENYLETHYNYL DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2538507C2 |
